LumaENT and Patient Satisfaction

NCT02611622 | Completed

• 1 other identifier: 201301163
• Study Type: interventional
• Target: 35
• Locations: 1 country
• Sites: 1

Brief Summary

Patient satisfaction is an important metric currently used to rate quality of healthcare in hospitals. Maximizing patient satisfaction scores is therefore significantly beneficial to any hospital establishment. Recent studies have shown patient satisfaction depends on multiple factors, including patient involvement in treatment decision-making processes and patients' knowledge of treatment options. Internal review of departmental patient satisfaction survey scores revealed deficits in the aforementioned areas of patient satisfaction, with the domains of "how well concerns were addressed", "explanation of tests and procedures" and "effort to include patients in decisions" having the lowest scores on patient satisfaction surveys. This highlights the gap in patient satisfaction that the Otolaryngology department seeks to improve on, so as to maximize patient satisfaction, and in turn, the quality of healthcare provided. The aim of this study is to assess the improvement in patient satisfaction scores that can be obtained by incorporating LUMA ENT™, a disease-specific multimedia patient education software, into the treatment decisions for thyroid disorders. LUMA ENT™ is a leading patient education software that provides visual anatomic animations of disease processes, disease progression and treatment options to improve patients' knowledge. Thyroid disorders have been chosen for study due to their high frequency of occurrence in the patient population and generalizability to a wide medical audience. The investigators will perform a single-blinded randomized-controlled study of patients visiting the physician practices of the Department of Otolaryngology for management of thyroid disorders. Participants will be randomized into control and intervention groups. Upon completion of the routine physician-patient clinical encounter, the intervention group will view a 5- minute LUMA ENT™ video discussing their specific thyroid condition, its natural progression history, and treatment options. They will have an opportunity to ask the physician any further questions that arise from viewing the video. The control group will not view the LUMA ENT video. Patient satisfaction surveys will then be provided to both groups at the end of the visit as is routinely done and scores subsequently compared.

Conditions

Thyroid

Outcome Measures

Primary Outcomes (1)

• Evaluate improvement in patient satisfaction scores obtained with the incorporation of LUMA ENT™ in pre-treatment counseling

  To compare survey domain scores, MANOVA will be used to explore differences between groups and control for confounders.

  Day 1

Study Arms (2)

Arm 1: Control

ACTIVE COMPARATOR

* Participants will be presented with envelopes labeled with a unique block-randomization code and asked to pick one * Once the participant selects an envelope, the research coordinator will verify whether the code assigns the patient to the control or the intervention group, without the knowledge of the otolaryngologist who will be blinded to participant randomization at this point. * Participants in the control group will proceed to filling out Demographic Survey and Patient Satisfaction Survey * Once completed, they will be given the opportunity to discuss any further questions or concerns about their thyroid condition with their otolaryngologist

Other: Survey

Arm 2: LUMA ENT™

EXPERIMENTAL

* Participants will be presented with envelopes labeled with a unique block-randomization code and asked to pick one * Once the participant selects an envelope, the research coordinator will verify whether the code assigns the patient to the control or the intervention group, without the knowledge of the otolaryngologist who will be blinded to participant randomization at this point. * Participants in the intervention group will proceed to viewing the LUMA ENT™ videos pertinent to their thyroid condition using either of the two iPADS (the videos should not last longer than 10 minutes) * Once video viewing is complete, participants will be given the opportunity to discuss any further questions or concerns about their thyroid condition with their otolaryngologist, especially as relates to questions that arise as a result of viewing the video * Subsequently, the participants will proceed to filling out Demographic Survey and Patient Satisfaction Survey

Behavioral: LUMA ENT™; Other: Survey

Interventions

LUMA ENT™ BEHAVIORAL

Arm 2: LUMA ENT™

Survey OTHER

Demographic and Patient Satisfaction Survey

Arm 1: Control; Arm 2: LUMA ENT™

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participants will be patients scheduled to visit the BJH/WU Department of Otolaryngology clinic for management of thyroid disorders (ranging from benign to cancerous nodules or masses) that will involve surgical interventions of complete or partial thyroidectomies.
• must be between the ages of 18 and 80
• may be male or female
• must understand spoken or written English language
• must be able to provide informed consent

You may not qualify if:

• Patients who have already undergone any thyroid surgery will be excluded

Sponsors & Collaborators

• Washington University School of Medicine: lead

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Links

• Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

MeSH Terms

Conditions

Thyroid Diseases

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Endocrine System Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Brian Nussenbaum, M.D.

  Washington University School of Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 18, 2015
• First Posted: November 23, 2015
• Study Start: August 7, 2013
• Primary Completion: October 21, 2015
• Study Completion: October 21, 2015
• Last Updated: February 20, 2017

Record last verified: 2017-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)